656-53-1Relevant articles and documents
Preparation method of 4-methyl-5-(2-acetoxyethyl) thiazole
-
Paragraph 0032-0038, (2021/07/14)
The invention relates to a preparation method of 4-methyl-5-(2-acetoxyethyl) thiazole, and discloses a preparation method of 4-methyl-5-(2-acetoxyethyl) thiazole, the 4-methyl-5-(2-acetoxyethyl) thiazole is obtained by reaction of 3-halogenated-5-acetoxy-2-pentanone and thioformamide, and the reaction takes SBA-15 molecular sieve loaded ionic liquid as a catalyst. The catalyst not only improves the reaction yield, but also improves the product purity.
Synthetic method of thiazoles (by machine translation)
-
, (2020/09/16)
4 - Acetoxy 3 - acetyl -3 - chloropropyl acetate is hydrolyzed under acidic conditions to prepare 4 -mercapto -2 - methyl -2 - (β - acetoxyethyl)-thiazole; the step of preparing -2 - methyl -2 - (β - acetoxyethyl)-thiazole with 3 - methyl -3 - (β - acetoxyethyl)-thiazole under acidic condition is carried out under an acidic condition by adding an oxidizing agent under an acidic condition in 3 -chloro -3 -methyl 2 - (β - acetoxyethyl)-thiazole in an acidic condition under an acidic condition by adding 4 - an oxidizing agent under an acidic condition; and a -5 - method -5 - for synthesizing thiazoles -4 - and -5 -mercapto 2 -methyl-ethyl)-thiazole in an acidic condition by adding an -5 - oxidizing agent under an -5 - 4 - acidic condition; and the method comprises the following steps: preparing -4 -4 - ethyl acetoxyethyl)-thiazole. The synthesis method is mild in overall reaction condition, simple in post-treatment and suitable for pilot scale test and industrial production. (by machine translation)
Synthesis of [thiazolium-2,2′-14C2]-SAR97276A from [14C]-thiourea
Herbert, John M.,Le Strat, Franck,Oumeddour, Delphine G.,Passey, Stephen C.,Taylor, Keith,Whitehead, David M.
experimental part, p. 89 - 92 (2011/10/02)
[thiazolium-2,2′-14C2]-SAR97276A, a bis(thiazolium) antimalarial development candidate, was synthesized from [ 14C]-thiourea with an overall radiochemical yield of 15%. The synthetic route involves a modified procedure for the synthesis of [ 14C]-sulfurol, also a key intermediate in thiamine synthesis, which was developed due to unlabelled chemistry proving irreproducible with the radiolabelled substrate. Copyright
C2, C5, and C4 azole N-oxide direct arylation including room-temperature reactions
Campeau, Louis-Charles,Bertrand-Laperle, Megan,Leclerc, Jean-Philippe,Villemure, Elisia,Gorelsky, Serge,Fagnou, Keith
, p. 3276 - 3277 (2008/10/09)
The N-oxide group imparts a dramatic increase in reactivity at all positions of the azole ring of thiazoles and imidazoles and changes the weak bias for C5 > C2 arylation to a reliable C2 > C5 > C4 reactivity profile. Use of this cross-coupling strategy enables high yielding and room-temperature C2 arylations, mild reactions at C5, and the first examples of C4 arylation-providing a unique opportunity for exhaustive functionalization of the azole core with complete control of regioselectivity. A correlation of reactivity with the relative contributions of each carbon atom to the HOMO is observed and discussed. Copyright
Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors
Thomas, Allen A.,Le Huerou,De Meese,Gunawardana, Indrani,Kaplan, Tomas,Romoff, Todd T.,Gonzales, Stephen S.,Condroski, Kevin,Boyd, Steven A.,Ballard, Josh,Bernat, Bryan,DeWolf, Walter,Han, May,Lee, Patrice,Lemieux, Christine,Pedersen, Robin,Pheneger, Jed,Poch, Greg,Smith, Darin,Sullivan, Francis,Weiler, Solly,Wright, S. Kirk,Lin, Jie,Brandhuber, Barb,Vigers, Guy
, p. 2206 - 2210 (2008/12/20)
Tumor cells extensively utilize the pentose phosphate pathway for the synthesis of ribose. Transketolase is a key enzyme in this pathway and has been suggested as a target for inhibition in the treatment of cancer. In a pharmacodynamic study, nude mice with xenografted HCT-116 tumors were dosed with 1 ('N3′-pyridyl thiamine'; 3-(6-methyl-2-amino-pyridin-3-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium chloride hydrochloride), an analog of thiamine, the co-factor of transketolase. Transketolase activity was almost completely suppressed in blood, spleen, and tumor cells, but there was little effect on the activity of the other thiamine-utilizing enzymes α-ketoglutarate dehydrogenase or glucose-6-phosphate dehydrogenase. Synthesis and SAR of transketolase inhibitors is described.